American Portfolios Advisors Haemonetics Corp Transaction History

American Portfolios Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 22, 2023	BUY	$51.81 - $118.56 $3,626 - $8,299	70 New	70 $4.67 Million
Q1 2021 Mar 22, 2023	BUY	$111.01 - $139.48 $7,770 - $9,763	70 New	70 $7.77 Million
Q4 2020 Mar 22, 2023	BUY	$88.75 - $119.95 $6,212 - $8,396	70 New	70 $8.31 Million
Q3 2020 Mar 22, 2023	BUY	$75.65 - $93.58 $5,295 - $6,550	70 New	70 $6.11 Million
Q1 2020 Mar 24, 2023	BUY	$74.34 - $121.82 $5,203 - $8,527	70 New	70 $6.98 Million
Q4 2019 Mar 24, 2023	BUY	$114.37 - $129.46 $8,005 - $9,062	70 New	70 $8.04 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.